Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06454773

To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Diabetes Foundation, India · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

This is randomized controlled parallel arm study on free living Asian Indians. Eligible subjects will undergo one-week run-in period and subjects will be asked to maintain their usual diet and exercise regime. At the end of the run-in period, subjects fulfilling the inclusion/exclusion criteria at this stage will be randomized either to the intervention arm or control arm using computerized random number tables. The measured parameters will include, 24-h diet recall, food frequency questionnaire, anthropometry including circumferences, height and weight, and blood parameters including blood glucose (fasting), serum insulin (fasting), HbA1c and lipid profile.

Detailed description

To study the impact of bioactive compound supplementation on fasting blood glucose. To study the impact of intervention with bioactive compound on following measures of glycaemia: * 24 hr AUC total from CGM Post-prandial glucose regulation * iAUC determined from CGM readout up to 2 hr after consumption of a Standard Meal Blood Chemistry * Fasting Insulin * HbA1c * Lipid profile Anthropometry * Weight * BMI * Waist Circumference

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNCT/NFTextract from black pepper and hemp hull

Timeline

Start date
2024-06-01
Primary completion
2024-12-01
Completion
2024-12-31
First posted
2024-06-12
Last updated
2024-06-12

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06454773. Inclusion in this directory is not an endorsement.